Details of the Drug Reposition

General Information of This Drug (ID: DMDNPAV)

Drug Name
TTI-621   DMDNPAV
Drug Type
Recombinant protein

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
6 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Mycosis fungoides DIS62RB8 2B01 Phase 1 [2]
Haematological malignancy DISCDP7W 2B33.Y Phase 1 [1]
Squamous cell carcinoma DISQVIFL 2B60-2D01 Phase 1 [2]
Melanoma DIS1RRCY 2C30 Phase 1 [2]
Merkel cell carcinoma DISDJJ4U 2C34 Phase 1 [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Indications(s)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)